{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:55:03Z","timestamp":1790294103235,"version":"4.1.0"},"reference-count":54,"publisher":"JLE","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1684\/ejd.2018.3449","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:21:36Z","timestamp":1696850496000},"page":"750-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Vitiligo and thyroid disease: a systematic review and meta-analysis"],"prefix":"10.1684","volume":"28","author":[{"given":"Kang-Chih","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"3449_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet 2015; 386: 74\u201384.","journal-title":"Lancet"},{"key":"3449_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","volume":"38","author":"SO Kovacs","year":"1998","unstructured":"Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647\u201366 (quiz: 667\u20138).","journal-title":"J Am Acad Dermatol"},{"key":"3449_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2165\/00128071-200102030-00006","volume":"2","author":"MD Njoo","year":"2001","unstructured":"Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment.Am J Clin Dermatol 2001; 2: 167\u201381.","journal-title":"Am J Clin Dermatol"},{"key":"3449_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.12998\/wjcc.v3.i3.221","volume":"3","author":"GF Mohammed","year":"2015","unstructured":"Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J Clin Cases 2015; 3: 221\u201330.","journal-title":"World J Clin Cases"},{"key":"3449_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2340\/00015555-1981","volume":"95","author":"C Kruger","year":"2015","unstructured":"Kruger C, Schallreuter KU. Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo. Acta Derm Venereol 2015; 95: 553\u20138.","journal-title":"Acta Derm Venereol"},{"key":"3449_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T, et al. Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2012; 25: E1\u201313.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3449_CR7","doi-asserted-by":"publisher","first-page":"631927","DOI":"10.1155\/2015\/631927","volume":"2015","author":"R Colucci","year":"2015","unstructured":"Colucci R, Dragoni F, Moretti S. Oxidative stress and immune system in vitiligo and thyroid diseases. Oxid Med Cell Longev 2015; 2015: 631927.","journal-title":"Oxid Med Cell Longev"},{"key":"3449_CR8","doi-asserted-by":"publisher","first-page":"518090","DOI":"10.1155\/2011\/518090","volume":"2011","author":"N Oiso","year":"2011","unstructured":"Oiso N, Suzuki T, Fukai K, et al. Nonsegmental vitiligo and autoimmune mechanism. Dermatol Res Pract 2011; 2011: 518090.","journal-title":"Dermatol Res Pract"},{"key":"3449_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1089\/thy.2010.1643","volume":"20","author":"RA Spritz","year":"2010","unstructured":"Spritz RA. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid 2010; 20: 745\u201354.","journal-title":"Thyroid"},{"key":"3449_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5114\/pdia.2014.43497","volume":"31","author":"R Czajkowski","year":"2014","unstructured":"Czajkowski R, Mecinska-Jundzill K. Current aspects of vitiligo genetics. Postep Dermatol Alergol 2014; 31: 247\u201355.","journal-title":"Postep Dermatol Alergol"},{"key":"3449_CR11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","volume":"167","author":"C Vrijman","year":"2012","unstructured":"Vrijman C, Kroon MW, Limpens J, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol 2012; 167: 1224\u201335.","journal-title":"Br J Dermatol"},{"key":"3449_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1365-2133.2012.11002.x","volume":"167","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Diallo A, Leaute-Labreze C, et al. Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. Br J Dermatol 2012; 167: 490\u20135.","journal-title":"Br J Dermatol"},{"key":"3449_CR13","doi-asserted-by":"publisher","first-page":"8065765","DOI":"10.1155\/2016\/8065765","volume":"2016","author":"L Lazzeri","year":"2016","unstructured":"Lazzeri L, Colucci R. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int 2016; 2016: 8065765.","journal-title":"Biomed Res Int"},{"key":"3449_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jaad.2011.07.010","volume":"66","author":"E Nicolaidou","year":"2012","unstructured":"Nicolaidou E, Antoniou C, Miniati A, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol 2012; 66: 954\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"3449_CR15","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, & The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.","journal-title":"PLoS Med"},{"key":"3449_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/9781444300161.ch12","volume-title":"Evidence-based dermatology","author":"M Radulescu","year":"2008","unstructured":"Radulescu M, Diepgen T, Williams HC. What makes a good prevalence survey?. In: Williams HC, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B, editors. Evidence-based dermatology, 2nd ed. Oxford: Blackwell Publishing, 2008, p. 61\u20137.","edition":"2nd ed."},{"key":"3449_CR17","doi-asserted-by":"publisher","first-page":"E1466","DOI":"10.1210\/jc.2011-0228","volume":"96","author":"S Hutfless","year":"2011","unstructured":"Hutfless S, Matos P, Talor MV, et al. Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. J Clin Endocrinol Metab 2011; 96: E1466\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"3449_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2133.2011.10311.x","volume":"165","author":"K Ezzedine","year":"2011","unstructured":"Ezzedine K, Diallo A, Leaute-Labreze C, et al. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol 2011; 165: 44\u20139.","journal-title":"Br J Dermatol"},{"key":"3449_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2133.2011.10650.x","volume":"166","author":"N Van Geel","year":"2012","unstructured":"Van Geel N, Mollet I, Brochez L, et al. New insights in segmental vitiligo: case report and review of theories. Br J Dermatol 2012; 166: 240\u20136.","journal-title":"Br J Dermatol"},{"key":"3449_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1365-4632.2008.03623.x","volume":"47","author":"EL Weisberg","year":"2008","unstructured":"Weisberg EL, Le LQ, Cohen JB. A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis. Int J Dermatol 2008; 47: 1053\u20135.","journal-title":"Int J Dermatol"},{"key":"3449_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/dth.12345","volume":"29","author":"M Kovacevic","year":"2016","unstructured":"Kovacevic M, Stanimirovic A, Vucic M, et al. Mixed vitiligo of Blaschko lines: a newly discovered presentation of vitiligo responsive to combination treatment. Dermatol Ther 2016; 29: 240\u20133.","journal-title":"Dermatol Ther"},{"key":"3449_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jaad.2005.03.032","volume":"53","author":"T Kakourou","year":"2005","unstructured":"Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, et al. Increased prevalence of chronic autoimmune (Hashimoto\u2019s) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol 2005; 53: 220\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"3449_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1365-2230.2009.03671.x","volume":"35","author":"Y Yang","year":"2010","unstructured":"Yang Y, Lin X, Fu W, et al. An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children. Clin Exp Dermatol 2010; 35: 706\u201310.","journal-title":"Clin Exp Dermatol"},{"key":"3449_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1468-3083.2010.03694.x","volume":"25","author":"SB Cho","year":"2011","unstructured":"Cho SB, Kim JH, Cho JM. Vitiligo in children and adolescents: association with thyroid dysfunction. J Eur Acad Dermatol Venereol 2011; 25: 64\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3449_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-4632.2010.04665.x","volume":"50","author":"S Uncu","year":"2011","unstructured":"Uncu S, Yayli S, Bahadir S, et al. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol 2011; 50: 175\u20139.","journal-title":"Int J Dermatol"},{"key":"3449_CR26","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.12659\/MSM.894981","volume":"21","author":"C Xianfeng","year":"2015","unstructured":"Xianfeng C, Yuegen J, Zhiyu Y, et al. Pediatric patients with vitiligo in eastern China: abnormalities in 145 cases based on thyroid function tests and immunological findings. Med Sci Monit 2015; 21: 3216\u201321.","journal-title":"Med Sci Monit"},{"key":"3449_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2133.1968.tb12282.x","volume":"80","author":"WJ Cunliffe","year":"1968","unstructured":"Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 1968; 80: 135\u20139.","journal-title":"Br J Dermatol"},{"key":"3449_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0140-6736(69)91421-4","volume":"2","author":"J Brostoff","year":"1969","unstructured":"Brostoff J. Autoantibodies in patients with vitiligo. Lancet 1969; 2: 177\u20138.","journal-title":"Lancet"},{"key":"3449_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2133.1975.tb03099.x","volume":"92","author":"H Woolfson","year":"1975","unstructured":"Woolfson H, Finn OA, Mackie RM, et al. Serum antitumour antibodies and auto-antibodies in vitiligo. Br J Dermatol 1975; 92: 395\u2013400.","journal-title":"Br J Dermatol"},{"key":"3449_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/archderm.1983.01650280028010","volume":"119","author":"PE Grimes","year":"1983","unstructured":"Grimes PE, Halder RM, Jones C, et al. Autoantibodies and their clinical significance in a black vitiligo population. Arch Dermatol 1983; 119: 300\u20133.","journal-title":"Arch Dermatol"},{"key":"3449_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1159\/000249466","volume":"171","author":"C Betterle","year":"1985","unstructured":"Betterle C, Caretto A, De Zio A, et al. Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 1985; 171: 419\u201323.","journal-title":"Dermatologica"},{"key":"3449_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1346-8138.1993.tb01363.x","volume":"20","author":"SK Hann","year":"1993","unstructured":"Hann SK, Im S, Kim HI, et al. Increased incidence of antismooth muscle antibody in Korean vitiligo patients. J Dermatol 1993; 20: 679\u201383.","journal-title":"J Dermatol"},{"key":"3449_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000247164","volume":"188","author":"KU Schallreuter","year":"1994","unstructured":"Schallreuter KU, Lemke R, Brandt O, et al. Vitiligo and other diseases: coexistence or true association? Dermatology 1994; 188: 269\u201375.","journal-title":"Dermatology"},{"key":"3449_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/0001555574124128","volume":"74","author":"L Hegedus","year":"1994","unstructured":"Hegedus L, Heidenheim M, Gervil M, et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994; 74: 120\u20133.","journal-title":"Acta Derm Venereol"},{"key":"3449_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2249.2003.02089.x","volume":"131","author":"G Zettinig","year":"2003","unstructured":"Zettinig G, Tanew A, Fischer G, et al. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol 2003; 131: 347\u201354.","journal-title":"Clin Exp Immunol"},{"key":"3449_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-5945-6-3","volume":"6","author":"M Daneshpazhooh","year":"2006","unstructured":"Daneshpazhooh M, Mostofizadeh GM, Behjati J, et al. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol 2006; 6: 3.","journal-title":"BMC Dermatol"},{"key":"3449_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/0378-6323.32710","volume":"73","author":"KVT Gopal","year":"2007","unstructured":"Gopal KVT, Rao GRR, Kumar YHK. Vitiligo: a part of a systemic autoimmune process. Indian J Dermatol Venereol Leprol 2007; 73: 162\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3449_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4161\/derm.19200","volume":"4","author":"M Rodriguez-Martin","year":"2012","unstructured":"Rodriguez-Martin M, Saez M, Merino de Paz N, et al. When are laboratory tests indicated in patients with vitiligo? Dermatoendocrinol 2012; 4: 53\u20137.","journal-title":"Dermatoendocrinol"},{"key":"3449_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5455\/medarh.2013.67.91-93","volume":"67","author":"E Kasumagic-Halilovic","year":"2013","unstructured":"Kasumagic-Halilovic E, Ovcina-Kurtovic N, Jukic T, et al. Vitiligo and autoimmunity. Med Arch 2013; 67: 91\u20133.","journal-title":"Med Arch"},{"key":"3449_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3923\/pjbs.2013.570.574","volume":"16","author":"SB Nejad","year":"2013","unstructured":"Nejad SB, Qadim HH, Nazeman L, et al. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak J Biol Sci 2013; 16: 570\u20134.","journal-title":"Pak J Biol Sci"},{"key":"3449_CR41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4103\/2229-5178.142493","volume":"5","author":"KV Gopal","year":"2014","unstructured":"Gopal KV, Rao GR, Kumar YH. Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: a case-control study. Indian Dermatol Online J 2014; 5: 456\u201360.","journal-title":"Indian Dermatol Online J"},{"key":"3449_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0019-5154.135485","volume":"59","author":"Y Yang","year":"2014","unstructured":"Yang Y, Huang G, Yan X, Qing Z. Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo. Indian J Dermatol 2014; 59: 357\u201360.","journal-title":"Indian J Dermatol"},{"key":"3449_CR43","doi-asserted-by":"publisher","first-page":"e22113","DOI":"10.17795\/jssc22113","volume":"1","author":"A Zamanian","year":"2014","unstructured":"Zamanian A, Mobasher P, Ansar A, et al. Autoimmune thyroid disorders in patients with vitiligo. J Skin Stem Cell 2014; 1: e22113.","journal-title":"J Skin Stem Cell"},{"key":"3449_CR44","first-page":"34","volume":"14","author":"M Biswas","year":"2015","unstructured":"Biswas M, Chattopadhyay A, Mridha K, et al. A study on association between vitiligo and thyroid dysfunction. IOSR-JDMS 2015; 14: 34\u20137.","journal-title":"IOSR-JDMS"},{"key":"3449_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/ajd.12321","volume":"56","author":"S Diaz-Angulo","year":"2015","unstructured":"Diaz-Angulo S, Lopez-Hoyos M, Munoz-Cacho P, et al. High prevalence of thyroid autoimmunity in patients with alopecia areata and vitiligo: a controlled study. Australas J Dermatol 2015; 56: 142\u20133.","journal-title":"Australas J Dermatol"},{"key":"3449_CR46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jaad.2016.12.034","volume":"76","author":"JM Bae","year":"2017","unstructured":"Bae JM, Lee JH, Yun JS, Han B, Han TY. Vitiligo and overt thyroid diseases: a nationwide population-based study in Korea. J Am Acad Dermatol 2017; 76: 871\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"3449_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000081479","volume":"210","author":"P Iacovelli","year":"2005","unstructured":"Iacovelli P, Sinagra JL, Vidolin AP, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 2005; 210: 26\u201330.","journal-title":"Dermatology"},{"key":"3449_CR48","first-page":"129","volume":"17","author":"O Arycan","year":"2008","unstructured":"Arycan O, Koc K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Pannonica Adriat 2008; 17: 129\u201332.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"3449_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/derm.1.1.7306","volume":"1","author":"M Tanioka","year":"2009","unstructured":"Tanioka M, Yamamoto Y, Katoh M, et al. Vitiligo vulgaris and autoimmune diseases in Japan: a report from vitiligo clinic in Kyoto University Hospital. Dermatoendocrinol 2009; 1: 43\u20135.","journal-title":"Dermatoendocrinol"},{"key":"3449_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/S0365-05962011000200006","volume":"86","author":"DH Nunes","year":"2011","unstructured":"Nunes DH, Esser LM. Vitiligo epidemiological profile and the association with thyroid disease. An Bras Dermatol 2011; 86: 241\u20138.","journal-title":"An Bras Dermatol"},{"key":"3449_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1468-3083.2011.04367.x","volume":"27","author":"V Pradhan","year":"2013","unstructured":"Pradhan V, Patwardhan M, Thakkar V, et al. Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries. J Eur Acad Dermatol Venereol 2013; 27: 279\u201386.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3449_CR52","doi-asserted-by":"publisher","first-page":"192736","DOI":"10.1155\/2015\/192736","volume":"2015","author":"R Dash","year":"2015","unstructured":"Dash R, Mohapatra A, Manjunathswamy BS. Anti-thyroid peroxidase antibody in vitiligo: a prevalence study. J Thyroid Res 2015; 2015: 192736.","journal-title":"J Thyroid Res"},{"key":"3449_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5114\/ada.2016.60617","volume":"33","author":"D Kartal","year":"2016","unstructured":"Kartal D, Borlu M, Cinar SL, et al. Thyroid abnormalities in paediatric patients with vitiligo: retrospective study. Postep Dermatol Alergol 2016; 33: 232\u20134.","journal-title":"Postep Dermatol Alergol"},{"key":"3449_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/ced.12771","volume":"41","author":"HK Lim","year":"2016","unstructured":"Lim HK, Bae MI, Jeong KH, et al. Positivity rates of antithyroid antibody, antinuclear antibody and thyroid peroxidase antibody in different types of vitiligo. Clin Exp Dermatol 2016; 41: 242\u20137.","journal-title":"Clin Exp Dermatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2018.3449\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:23:30Z","timestamp":1741173810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3449"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2018.3449","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"12 Juni 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 Mai 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}